Policy or Program
|
Any future work of the Commission on the Future of Health Care in Canada.
|
Regulation
|
Health Canada's proposal to add the drug tramadol to the Controlled Drugs and Substance Act (CDSA) and the Schedule of the Narcotic Control Regulations (NCR).
|
Regulation
|
Health Canada's Regulations Amending the Food and Drug Regulations.
|
Policy or Program
|
The House of Commons Standing Committee on Health's (HESA) study of the Status of and progress accomplished under the Common Drug Review (CDR) and its study of Post Marketing Surveillance
|
Regulation
|
The monitoring of Health Canada's enforcement of Canada's Food and Drugs Act and Regulations as they relate to the cross border sale of drugs to the United States.
|
Regulation
|
The monitoring of Industry Canada's Regulations Amending the Patented Medicines (Notice of Compliance) Regulations ("PM(NOC) Regulations").
|
Policy or Program
|
The on-going work of the Patented Medicine Prices Review Board as it relates to the pricing of Janssen-Ortho molecules and drugs.
|